Process Engineering STREAM

  1. Adoption And Implementation 9/17/2024

    Here, our panelists share their thoughts on what factors to consider when adopting or implementing new AI/ML technology into your biomanufacturing process.

  2. Nanoassemblr Blaze mRNA Vaccine Demo 4/13/2022

    NxGen Technology delivers a scalable means to perform the critical particle formation step in a nanomedicine development process.

  3. Accelerating Novel Cell Therapies To Market 3/20/2024

    Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.

  4. Advances In Custom Medium Development: The Multi-Omics Difference 6/9/2025

    Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.

  5. Process Optimization And Control 9/17/2024

    Our panelists share their thoughts on how companies should use AI for process optimization and control, stressing the importance of keeping humans in the loop.

  6. ADC Heterogeneity, Site-Specific Conjugation 4/29/2025

    This busy segment of the Bioprocess Online Live panel discussion Accelerating ADC Process Development finds Dr. Léo Marx (Debiopharm), Dr. Monika Lamba Saini (ADC Therapeutics), and Dr. Philipp Spycher (Araris Biotech) addressing DAR variability and lipophilic toxicity, homogeneity, computational tools to address molecular design and ADC behavior, and revisiting strategic considerations in CDMO selection before addressing a second live poll of our audience. 

  7. Inside Bioprocessing: Continuous Perfusion 11/4/2025

    Learn about the essential elements of upstream workflows, media optimization strategies, and liquid handling logistics required to implement continuous perfusion successfully.

  8. Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit 3/13/2026

    See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.

  9. A Closed And Automated Solution For Cell Therapy Manufacturing 3/1/2024

    Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.

  10. Leveraging Single-Use Bioreactors In Bench-Scale Process Development 11/6/2025

    Scaling bioprocesses requires matching critical variables to ensure consistent cell behavior and product quality. Optimize operations with efficient tools that enable more experiments per year.